Skip to content

Abacavir/3TC/tenofovir study stopped due to high failure rate

Drug resistant HIV found in 10% of untreated Europeans

Alternating drug regimens may delay HIV treatment failure

Formula feed is `medicine to prevent HIV`

Kaletra: could upping the dose overcome resistance?

Atazanavir/ritonavir comparable to lopinavir/ritonavir in PI-experienced

US HIV guidelines: choose either lopinavir or efavirenz in first-line treatment

TB drugs should be free for all, says WHO

Week on, week off treatment strategy buried at Paris conference